UBS Stays Bullish on Oracle (ORCL) Despite Target Cut, Sees 2026 Recovery Path

Oracle Corporation (NYSE:ORCL) is one of the AI Stocks on the Market's Radar. On January 5, UBS reiterated the stock as “Buy” and lowered its price target to 280persharefrom280 per share from 325. The firm is cautiously optimistic on the stock as it sees recovery potential tied to OpenAI sentiment shift and Abilene capacity ramp. The analysts noted how Oracle’s 41% share correction from mid-September highs is a reflection of deteriorating investor confidence in Oracle outlook as well as OpenAI’s prospects. Apprehens ...